Literature DB >> 23739999

Less glucuronidation of morphine in the presence of ethanol in vivo.

Gudrun Høiseth1, Jannike Mørch Andersen, Jørg Mørland.   

Abstract

PURPOSE: Ethanol and morphine are both substrates of uridine diphosphate glucuronosyl transferases (UGTs). A pharmacokinetic interaction between ethanol and morphine is suggested from in vitro studies, but to our knowledge not documented in vivo. The aim of this study was to compare the ratios between M6G and morphine and between M3G and morphine in blood samples from suspected drunk and drugged drivers, with and without presence of ethanol.
METHODS: The data in the present study constitute all cases of suspected drunk and drugged driving positive for morphine, collected in Norway, in the period November 1st 2009 to December 1st 2012, during which all morphine positive cases were also routinely analysed for M6G and M3G. The cases were divided into two groups; one where morphine was present together with ethanol (group 1) and one where morphine was present in the absence of ethanol (group 2).
RESULTS: The ratios between M3G and morphine was lower in the ethanol positive cases, i.e. mean 4.9 (95 % CI 4.03-5.79) in group 1 and mean 6.7 (95 % CI 6.35-7.00) in group 2 (p < 0.001). The ratios between M6G and morphine was also lower in the ethanol positive cases, i.e. mean 0.62 (95 % CI 0.42-0.81) in group 1 and mean 0.96 (95 % CI 0.89-1.02) in group 2 (p = 0.001).
CONCLUSIONS: This study indicated that the metabolism of morphine may be changed in the presence of ethanol, resulting in less formation of the metabolites. This could lead to increased terminal half-life for morphine and also possibly more accumulation after repeated dosing.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23739999     DOI: 10.1007/s00228-013-1533-5

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

1.  Assessment of UDP-glucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs.

Authors:  Robert S Foti; Michael B Fisher
Journal:  Forensic Sci Int       Date:  2005-01-15       Impact factor: 2.395

Review 2.  Drug glucuronidation in clinical psychopharmacology.

Authors:  H L Liston; J S Markowitz; C L DeVane
Journal:  J Clin Psychopharmacol       Date:  2001-10       Impact factor: 3.153

3.  Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse.

Authors:  Alaa Al Saabi; Delphine Allorge; François-Ludovic Sauvage; Gilles Tournel; Jean-Michel Gaulier; Pierre Marquet; Nicolas Picard
Journal:  Drug Metab Dispos       Date:  2012-12-10       Impact factor: 3.922

4.  Effects of chronic ethanol consumption on carcinogen activating and detoxifying systems in rat upper alimentary tract tissue.

Authors:  F Farinati; C S Lieber; A J Garro
Journal:  Alcohol Clin Exp Res       Date:  1989-06       Impact factor: 3.455

5.  A pharmacokinetic study of ethyl glucuronide in blood and urine: applications to forensic toxicology.

Authors:  Gudrun Høiseth; Jean Paul Bernard; Ritva Karinen; Lene Johnsen; Anders Helander; Asbjørg S Christophersen; Jørg Mørland
Journal:  Forensic Sci Int       Date:  2007-02-16       Impact factor: 2.395

6.  Determination of opiates and cocaine in urine by high pH mobile phase reversed phase UPLC-MS/MS.

Authors:  Thomas Berg; Elsa Lundanes; Asbjørg S Christophersen; Dag Helge Strand
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-12-27       Impact factor: 3.205

7.  Mechanisms behind the inhibitory effect of ethanol on the conjugation of morphine in rat hepatocytes.

Authors:  E Bodd; G Gadeholt; P I Christensson; J Mørland
Journal:  J Pharmacol Exp Ther       Date:  1986-12       Impact factor: 4.030

8.  Blood kinetics of ethyl glucuronide and ethyl sulphate in heavy drinkers during alcohol detoxification.

Authors:  Gudrun Høiseth; Luca Morini; Aldo Polettini; Asbjørg Christophersen; Jørg Mørland
Journal:  Forensic Sci Int       Date:  2009-04-23       Impact factor: 2.395

Review 9.  Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios.

Authors:  J Andrew Williams; Ruth Hyland; Barry C Jones; Dennis A Smith; Susan Hurst; Theunis C Goosen; Vincent Peterkin; Jeffrey R Koup; Simon E Ball
Journal:  Drug Metab Dispos       Date:  2004-08-10       Impact factor: 3.922

10.  Ethanol inhibition of codeine and morphine metabolism in isolated rat hepatocytes.

Authors:  E Bodd; C A Drevon; N Kveseth; H Olsen; J Mørland
Journal:  J Pharmacol Exp Ther       Date:  1986-04       Impact factor: 4.030

View more
  2 in total

1.  Quantifying enhanced risk from alcohol and other factors in polysubstance-related deaths.

Authors:  Zheng Dai; Marie A Abate; D Leann Long; Gordon S Smith; Theresa M Halki; James C Kraner; Allen R Mock
Journal:  Forensic Sci Int       Date:  2020-05-31       Impact factor: 2.395

Review 2.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.